Profound Medical (NASDAQ:PROF) reported its Q4 earnings results on Thursday, March 7, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Profound Medical missed estimated earnings by -31.0%, reporting an EPS of $-0.42 versus an estimate of $-0.32.
Revenue was up $700 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.08 which was followed by a 5.0% increase in the share price the next day.
Here's a look at Profound Medical's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.34 | -0.34 | -0.34 | -0.36 |
| EPS Actual | -0.26 | -0.35 | -0.32 | -0.46 |
| Revenue Estimate | 2.06M | 2.17M | 2.11M | 2.72M |
| Revenue Actual | 1.73M | 1.60M | 1.86M | 1.30M |
To track all earnings releases for Profound Medical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.